They should have been banned:
It was “a success for the entire advertising community,” Dan Jaffe, executive vp of the Association of National Advertisers, a trade group, tells the paper. Lobbying groups including the National Association of Broadcasters and the Advertising Coalition, which rep a variety of media interests and advertisers, swung into action. To them, the idea that regulators would be able to block ads about a new drug was a business disaster in the making.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
